As of August 19, 2026, the AOR review has been moved out of the Chief Medical Officer's (CMO) office. This development was reported in a source article, though specific details regarding the reason for the move or the new location have not been disclosed.
The AOR review, which stands for 'Area of Review' or 'Aid and Attendance' in some contexts, is a process that typically involves evaluating medical or administrative procedures. However, without further information, the exact nature of this review remains unclear.
This change may have implications for the oversight and management of the review process, potentially affecting stakeholders who rely on the CMO's office for guidance. Further updates are expected as more information becomes available.
